Skip to main content

Perrigo Company Value Stock - Dividend - Research Selection

Perrigo

ISIN: IE00BGH1M568 , WKN: A1XAEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Perrigo (PRGO) Price Target Decreased by 11.61% to 16.83

2026-03-27

Perrigo: Double-Digit Dividend At A Bargain Price

2026-03-25
Perrigo offers a compelling value with a 12% dividend yield and a P/E of 4.3, trading at a deep discount to fair value. Click here to read why PRGO is a Buy.

Canaccord’s Susan Anderson Trims Perrigo (PRGO) Target but Notes Share Gains in Core Business

2026-03-16
Perrigo Company plc (NYSE:PRGO) is included among the 13 Extreme Dividend Stocks with Huge Upside Potential. On February 27, Canaccord analyst Susan Anderson lowered the firm’s price recommendation on Perrigo Company plc (NYSE:PRGO) to $17 from $20. It reiterated a Buy rating on the shares. The firm said management noted that the company finished Q4 […]

Risk-Savvy Investors Love 4 Passive Income Kings Yielding 10% and More

2026-03-12
Investors love ultra-high-yield dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time. In other words, the total return on an investment or portfolio consists of income and stock appreciation. At 24/7 Wall St., we have ... Risk-Savvy Investors Love 4 Passive Income Kings Yielding 10% and More

UBS Global Consumer and Retail Conference

2026-03-11
2026-03-11. The following slide deck was published by Perrigo Company plc in conjunction with this event.

Perrigo Company plc (PRGO) Presents at UBS Global Consumer and Retail Conference Transcript

2026-03-11

8 Stocks to Buy as Merger-Mania Takes Over

2026-03-10
Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, semiconductors, medical devices, and media.

Perrigo (PRGO) Is Down 18.9% After Deepening Net Loss and Weak 2026 Outlook - What's Changed

2026-03-07
Perrigo Company plc recently reported its fourth quarter and full-year 2025 results, posting full-year sales of US$4.25 billion, a much larger net loss of US$1.43 billion, and a wider loss per share compared with the prior year. Alongside these results, Perrigo issued a 2026 outlook calling for a 1.5%–5.5% sales decline, signaling ongoing business pressures at a time when investors had been focused on a potential earnings recovery. We’ll now examine how Perrigo’s sharp increase in full-year...

Perrigo to Present at the UBS Global Consumer and Retail Conference

2026-03-03
Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer products, today announced that President and CEO Patrick Lockwood-Taylor is scheduled to present at the UBS Global Consumer and Retail Conference, on Wednesday, March 11th at 11:00 AM EDT.

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

2026-03-03
Investors turn to dividend-yielding stocks during market turbulence. Benzinga offers latest analyst ratings and news on high-yielding stocks in the health care sector, including PRGO and PFE.